HLB Pharmaceutical CEO Park Jae Hyung raises stake to 1.51% via paid-in capital increase at KRW 5,650/share

PUBT · 1d ago
HLB Pharmaceutical CEO Park Jae Hyung raises stake to 1.51% via paid-in capital increase at KRW 5,650/share
  • HLB Pharmaceutical CEO Park Jae Hyung’s stake held steady at 657,378 shares, or 1.51%, as of Sept. 21, 2026.
  • Common shares rose by 92,652 to 657,378 through a paid-in rights offering priced at KRW 5,650 per share.
  • Warrants for 92,652 shares expired following the capital increase, leaving total voting shares unchanged.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HLB Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260928000103), on September 28, 2026, and is solely responsible for the information contained therein.